[Federal Register Volume 62, Number 99 (Thursday, May 22, 1997)]
[Notices]
[Pages 28037-28042]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-13425]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[Announcement 752]


Health Services Research on Sexually Transmitted Diseases 
Prevention Within Managed Care Settings

Introduction

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 1997 funds for applied health services 
research projects on sexually transmitted diseases (STDs) prevention 
within managed care settings.
    CDC is committed to achieving the health promotion and disease 
prevention objectives of ``Healthy People 2000,'' a national activity 
to reduce morbidity and mortality and improve the quality of life. This 
announcement is related to the priority area of Sexually Transmitted 
Diseases (STDs). (To order a copy of ``Healthy People 2000,'' see the 
Section ``WHERE TO OBTAIN ADDITIONAL INFORMATION.'')

Authority

    This program is authorized under Section 318 of the Public Health 
Service Act (42 U.S.C. 247C), as amended.

Smoke-Free Workplace

    CDC strongly encourages all grant recipients to provide a smoke-
free workplace and to promote the non-use of all tobacco products, and 
Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in 
certain facilities that receive Federal funds in which education, 
library, day care, health care, and early childhood development 
services are provided to children.

Eligible Applicants

    Applications may be submitted by public and private, nonprofit and 
for-profit organizations and governments and their agencies. Thus, 
universities, colleges, research institutions, hospitals, other public 
and private organizations, State and local health departments or their 
bona fide agents or instrumentalities, federally recognized Indian 
tribal governments, Indian tribes or Indian tribal organizations, 
small, minority, or women-owned businesses, managed care organizations 
and clinical public health entities such as: sexually transmitted 
disease (STD) clinics and family planning clinics are eligible to 
apply.
    Applications from health departments, Indian tribal governments, 
academic institutions, and contractors will be required to demonstrate 
partnership with a managed care organization, and applications from 
managed care organizations will be required to demonstrate partnership 
with a State or local health department. All eligible applicants must 
have research capacity involving previous experience with health 
services research, and access to relevant clinic populations such as 
adolescents, women, minorities, and Medicaid populations.

Availability of Funds

    Approximately $650,000 is available in FY 1997 to fund up to a 
total of five awards in four research areas. It is expected that the 
average award will be $200,000, ranging from $100,000 to $300,000. 
Specifically, organizations may submit applications in EACH or ANY of 
the following four research areas:
    1. STD-Managed Care Prevention Services Survey. (1 year funding)
    2. Quality of Service Studies. (2-3 years funding)
    3. Notifiable Disease Reporting and Information Systems Studies. 
(2-3 years funding)
    4. Population-Level STD Prevention Studies. (2-3 years funding)
    It is expected that awards will begin on or about September 15, 
1997, and will be made for a 12-month budget period within a one to 
three year project period. Funding estimates may vary and are subject 
to change. Continuation awards within the project period will be made 
on the basis of satisfactory progress and the availability of funds.

Use of Funds

    Funds are awarded for a specifically defined purpose and may not be 
used for any other purpose or program. Funds may be used to support 
personnel and to purchase equipment, supplies, and services directly 
related to project activities. Funds may not be used to supplant State 
or local health department funds or for inpatient care, medications, or 
construction.

Restricitons on Lobbying

    Applicants should be aware of restrictions on the use of HHS funds 
for

[[Page 28038]]

lobbying of federal or state legislative bodies. Under the provisions 
of 31 U.S.C. Section 1352 (which has been in effect since December 23, 
1989), recipients (and their subtier contractors) are prohibited from 
using appropriated federal funds (other than profits from a federal 
contract) for lobbying Congress or any federal agency in connection 
with the award of a particular contract, grant, cooperative agreement, 
or loan. This includes grants/cooperative agreements that, in whole or 
in part, involve conferences for which federal funds cannot be used 
directly or indirectly to encourage participants to lobby or to 
instruct participants on how to lobby.
    In addition, the FY 1997 HHS Appropriations Act, which became 
effective October 1, 1996, expressly prohibits the use of 1997 
appropriated funds for indirect or ``grass roots'' lobbying efforts 
that are designed to support or defeat legislation pending before state 
legislatures. This new law, Section 503 of Pub. L. No. 104-208, 
provides as follows:
    Sec. 503(a) No part of any appropriation contained in this Act 
shall be used, other than for normal and recognized executive-
legislative relationships, for publicity or propaganda purposes, for 
the preparation, distribution, or use of any kit, pamphlet, booklet, 
publication, radio, television, or video presentation designed to 
support or defeat legislation pending before the Congress, * * * except 
in presentation to the Congress or any State legislative body itself.
    (b) No part of any appropriation contained in this Act shall be 
used to pay the salary or expenses of any grant or contract recipient, 
or agent acting for such recipient, related to any activity designed to 
influence legislaiton or appropriations pending before the Congress or 
any State legislature. Department of Labor, Health and Human Services, 
and Education, and Related Agencies Appropriations Act, 1997, as 
enacted by the Omnibus Consolidated Appropriations Act, 1997, Division 
A, Title I, Section 101(e), Pub. L. No. 104-208 (September 30, 1996).

Background

    The recent Institute of Medicine (IOM) report ``The Hidden 
Epidemic: Confronting Sexually Transmitted Diseases'' (NAP 96) 
concluded that STDs represent a tremendous health and economic burden 
in the United States (U.S.). That committee recommended that 
comprehensive high quality STD-related health services be available to 
all persons.
    Managed care represents a revolution in the way health care is 
funded, organized, and delivered in the U.S. This has and will continue 
to have impact on the way in which STD prevention is conducted in both 
the private and public sectors. In the public sector, many health 
departments are in some stage of transition from directly delivering 
clinical services in categorical clinics to utilizing other delivery 
models that involve managed care. Thus, in the private sector, managed 
care providers play a key role in the way STDs are diagnosed and 
managed for increasing numbers of Americans. With more diagnostic and 
treatment services for STDs moving into the private sector, new 
partnerships are needed between Managed Care health plans and public 
health agencies to design and implement essential STD-related services 
in innovative ways.

Purpose

    The purpose of this applied health services research program is to 
develop a knowledge base through published research in scientific 
literature which will improve delivery of STD prevention services 
within managed care settings. Such a knowledge base includes a variety 
of activities covering the range of STD interventions, such as risk 
assessment, screening asymptomatically infected persons, early 
diagnosis of infected persons, treatment, partner notification and 
management, notification of reportable diseases, counseling, and 
laboratory services.
    This program also seeks to improve the availability, accessibility, 
delivery, quality, effectiveness, cost-effectiveness, and outcomes of 
STD prevention services in managed care health plans. The objectives 
include provision of data for policy development, assessment, and 
capacity building at the State and local level with respect to managed 
care and the health department's ability to develop appropriate STD 
prevention policies and to conduct STD surveillance in a changing 
environment.
    It is anticipated that an additional benefit will be to establish 
new partnerships and relationships between managed care health plans 
and public health agencies that will collaboratively address the 
challenges of improving the delivery of STD treatment and prevention 
services.

Program Requirements

    Work performed under this agreement will be the result of 
collaborative efforts. Recipients will be responsible for research 
methods and design, analysis, use of data and dissemination via peer 
publications or other related material. CDC will coordinate these 
collaborative efforts and expects to work closely with each award 
recipient.
    In conducting activities to achieve the purpose of this program, 
the recipient will be responsible for the activities under A. 
(Recipient Activities), and CDC will be responsible for the activities 
under B. (CDC Activities).

A. Recipient Activities

    In conducting activities to achieve the purpose of this program, 
the recipient will:
1. STD-Managed Care Prevention Services Survey:
    Develop a nationally representative health services survey 
examining the extent and characteristics of STD care that occur within 
managed care health plans. The survey is expected to address the 
following questions:
    a. How alternative managed care systems affect access and 
utilization, quality, cost and outcomes of STD-related treatment and 
prevention services. This would address issues related to laboratory, 
screening, counseling, treatment, health promotion, STD case 
management, partner management. This would also address the extent to 
which diagnosis and treatment of STDs is syndromic (i.e., presumptive 
STD diagnosis and empirical treatment based on symptoms and physical 
examination alone).
    b. How STD care and delivery of prevention services vary with 
organization, structure, and financing of health plans, specifically 
with respect to type of services offered, access, and quality 
(including patient satisfaction). For example:
    (1) Address the characteristics (including demographic 
characteristics such as age, race/ethnicity, income, occupation, 
socioeconomic status, type of insurance) of those enrolled. Also 
address the characteristics of those actually receiving care (e.g., 
what is the coverage?), and discuss how plans target adolescents, 
women, high-risk patients, and underserved population groups of 
interest.
    (2) Address the organizational linkages to essential components of 
STD services not provided by a health plan (e.g., partner notification, 
counseling). Also address whether or not referral is occurring, and how 
is it handled (e.g., what is the nature of the referral arrangements?)
2. Quality of Service Studies:
    Conduct studies to improve the quality of STD prevention services 
to promote early detection, effective

[[Page 28039]]

treatment, and follow up of STDs within managed care health plans. 
Projects should consider how the information could be used by consumers 
and purchasers to improve decision making. One or both of the following 
items must be addressed:
    a. Develop and test STD-related performance measures and other 
quality measurement tools to improve quality assurance monitoring in 
health plans and other clinical venues. Recipients will address the 
issue of data and use of information systems that support the 
assessment, analysis and evaluation aspects of performance monitoring.
    b. Conduct demonstration projects that will improve access to high-
quality STD-related services. These may focus on interventions for 
providers or for patients, and may address issues of access, screening, 
diagnosis, treatment, counseling and education, or partner management. 
Recipients should pay special attention to the effectiveness and 
outcomes of the interventions studied.
3. Notifiable Disease Reporting and Information Systems Studies:
    Conduct studies to develop and evaluate information systems that 
can meet the internal data requirements of managed care plans while 
improving the completeness and accuracy of surveillance and disease 
reporting activities of the plan. Recipients should:
    a. Assess the current status of electronic information systems in 
the health plan and associated health department, document their 
characteristics, and determine the feasibility for data sharing. 
Elements to be considered are: disease (morbidity) data, laboratory 
data, encounter data, pharmacy data, and use of and integration with 
existing systems such as sexually transmitted diseases management 
information system (STD*MIS), national electronic transmission 
surveillance (NETS), health plan and employer data information set 
(HEDIS), public health laboratory information system (PHLIS), or other 
equivalent State health department data collection system.
    b. Address the issues of confidentiality of data and the use of 
data for reimbursement of services provided by health departments.
4. Population-Leveled STD Prevention Studies:
    Conduct studies that involve the development and testing of 
interventions based on collaborative partnerships to achieve 
population-level goals (e.g., to decrease transmission and not just 
treat symptoms and prevent sequelae). One or both of the following 
items must be addressed:
    a. How managed health care plans can adopt public health preventive 
measures. An example of this would be to develop and evaluate methods 
for plans to effectively manage sex partners of members who are 
diagnosed with an STD to prevent re-infection and reduce further 
transmission. Another example would be to develop and evaluate methods 
for provider-based counseling or education.
    b. How managed health care plans can target or reconfigure existing 
services to reduce disease transmission within the community. An 
example of this would be to develop and evaluate methods for screening 
health plan members at risk for STDs who do not otherwise present for 
care. Another example would be to develop cost-effective risk 
assessment and targeted screening protocols for use in primary care 
settings to reduce the incidence of pelvic inflammatory disease.

B. CDC Activities

    1. Assist recipients to develop, pilot test, and implement 
protocols and instruments.
    2. Provide scientific and technical guidance in the general 
operations.
    3. Provide advice in monitoring and evaluating scientific and 
operational accomplishments.
    4. Assist in data analysis and presentation and reporting of 
research materials and results.
    5. Monitor the recipient's performance of program activities, 
protection of client confidentiality and compliance with other 
requirements.
    6. Provide technical assistance that may be needed to improve 
electronic data transmission between reporting organizations and 
associated health departments.

Technical Reporting Requirements

    An original and two copies of a quarterly progress report must be 
submitted no later than 30 days after the end of each budget quarter. 
An original and two copies of a financial status report (FSR) is 
required no later than 90 days after the end of each budget period. A 
final progress report and FSR are due no later than 90 days after the 
end of the project period. All reports will be submitted to the Grants 
Management Branch, CDC.

Application Content

    Applicatons must be developed in accordance with PHS Form 5161-1 
(OMB Number 0927-0189), information contained in the program 
announcement, and the instructions and format provided below.
    Applicants are required to submit an original and two copies of the 
application. Number each page clearly and sequentially, and provide a 
complete index to the application and its appendices. The original and 
each copy of the application set must be submitted UNSTAPLED and 
UNBOUND. All material must be typewritten, double spaced, with 
unreduced type on 8\1/2\'' by 11'' paper, with at least 1'' margins, 
headings and footers, and printed on one side only. Materials which 
should be part of the basic application will not be accepted if placed 
in the appendices.
    If an applicant responds to more than one research area, each 
research area must be addressed separately, including a separate 
project-specific narrative, budget, and attachments.
    The application must include an executive summary not to exceed 
four pages. The application must also include:
1. Background
    a. Describe the STD clinical and preventive health services 
available in the community and within the managed care health plan.
    b. Describe the epidemiology of gonorrhea, chlamydia, and primary 
and secondary (P&S) syphilis in calendar year 1995 for the proposed 
project area.
    c. Describe those at risk for STDs and their access to health care, 
the percentage uninsured, unemployed, under the poverty level, and 
those receiving Temporary Assistance for Needy Families (TANF), 
formerly Aid to Families with Dependent Children.
    d. Describe the managed care system and extent of managed care 
penetration and competition with the local or regional health care 
market. Describe the managed care structure, organization and 
financing, and the percentage of Medicaid population under managed care 
contracts and of those at risk for STDs under managed care contracts.
    e. Include additional background on any health care reform 
legislation, policies and additional environmental and socio-
demographic factors that may be relevant to the study of STD services 
in managed care. Examples include privatiization of categorical STD 
clinics, existing or pending Federal Medicaid waivers, and the extent 
to which existing Medicaid managed care contracts address public health 
issues, existing contracts, memoranda of understanding, agreements or 
arrangements between health plans and health departments.

[[Page 28040]]

2. Site Selection
    Define a project area based on specific information included in the 
background.
3. Objectives
    Provide a focused research agenda with long-term and short-term 
objectives that is realistic, specific, measurable, time-phased, and 
consistent with the objectives of the announcement.
4. Methods
    Described the methods and activities that will be undertaken to 
accomplish the objectives, including, where applicable, outcomes to be 
evaluated (i.e., health services-related outcomes, program-related 
outcomes, or STD specific health-related outcomes), the use of 
appropriate comparison groups, the sampling scheme and sample size 
calculations, qualitative and quantitative methods, and how data will 
be accessed, collected and used.
5. Evaluation Plan
    Applications must provide an evaluation plan to monitor the 
effectiveness of the project activities and the progress made towards 
meeting the objectives.
6. Partnerships
    Applications from health departments, academic institutions, and 
contractors will be required to demonstrate partnership with a managed 
care organization. Applications from managed care organizations will be 
required to demonstrate partnership with a State or local health 
department.
    Provide evidence of partnership and documentation of the commitment 
of collaborating organizations, agencies or individual researchers. 
Include letters summarizing the nature of the collaboration and 
indicating support. Letters should be signed by the chair of an 
academic department and the Dean of the institution; the STD program 
manager and director of communicable disease control or health officer; 
the director of research (if applicable), and medical director or other 
senior officer of the health plan.
7. Research Capacity
    Provide evidence of health services research capability. Describe 
past and current research experience, including the experience of the 
proposed staff who will participate in this project (include details of 
experience and competence in research design, data collection, analysis 
and dissemination). Attach the curriculum vitae of key staff. Describe 
your plan for project administration.
    The research team should include qualified and experienced 
personnel. Health services research is an interdisciplinary field 
drawing on theory and methods from biostatistics, epidemiology, 
medicine, health economics, sociology, operations research, psychology, 
nursing, and other disciplines. Thus, qualified researchers may come 
from a variety of fields but must have appropriate training and 
experience, and previous involvement with health services research 
projects. Minimum requirements for the research team are a principle 
investigator, statistician, and data manager.
8. Access to Populations At Rick For STDs
    Applications must also provide evidence of access to relevant 
clinic populations such as adolescents, women, minorities, and Medicaid 
populations.
9. Budget
    Provide a detailed, line-item budget for the project and a budget 
narrative that justifies each line-item.

Review and Evaluation Criteria

    If an applicant applies for more than one research area, each 
proposal will be evaluate separately. Applications will be reviewed and 
evaluated according to the following criteria:
    1. Background and Objectives (15 points)--Understanding of purpose 
and objectives of this research as reflected in the statement of 
research background and research questions.
    2. Site Selection (10 points)--The extent to which the choice of a 
site to conduct this research is appropriate to the objectives, STD 
epidemiology, social demography, and managed health care system. 
Emphasis will be placed on demonstrated access to one or more 
populations considered at high risk for STDs and their complications, 
including adolescents, women, minorities, or Medicaid enrollees in the 
project area.
    3. Methods (25 points)--The appropriateness and adequacy of the 
research design and methodology proposed to answer the research 
questions. This includes: (a) the selection of appropriate outcomes 
related to health services, STD programs, and STD morbidity; (b) the 
use of appropriate comparison groups; (c) the inclusion of appropriate 
sampling schemes, sample size calculation, handling of sampling biases; 
(d) access to the relevant data sources and the plan for data 
collection and; (e) the description of the specific quantitative and 
qualitative analytic technique to be used to answer the research 
questions.
    4. Evaluation (10 points)--The extent to which the applications 
present a sound evaluation plan that includes aspects such as: research 
progress measurements and communications, baseline data collection; 
intervention(s) testing, determination of intervention(s) 
effectiveness; and economic evaluation.
    5. Partnerships (20 points)--The extent to which the proposed 
research is interdisciplinary, programmatically relevant, and 
establishes effective collaborative partnership arrangements necessary 
for the research. The extent to which the application includes letters 
from the appropriate persons summarizing the nature of the 
collaboration and indicating support.
    6. Research Capacity (20 points)--Overall ability to perform the 
technical aspects of the project including: (a) the availability of 
qualified and experienced personnel for a multi-disciplinary team in 
health services research (including level of education and training, 
and relevant research experience of the principle investigator and key 
research personnel; (b) the availability of adequate facilities, 
general environment, and resources for the conduct of the proposed 
research and; (c) plans for the administration of the project(s), 
including a detailed and realistic schedule for the specified 
activities.
    7. Budget (not scored)--The appropriateness of budget estimates in 
relation to the proposed research. The extent to which budget is 
reasonable, clearly justified, and consistent with the intended use of 
funds.

Funding Preferences

    CDC reserves the right to make final funding selections based on 
geographic diversity, the level of STD in an applicants area/
jurisdiction, and coverage of the research activities across 
applications. Matching funds: applicants are asked to demonstrate a 
commitment to provide matching funding with a letter from a private 
source, such as a foundation or managed care organization. Preference 
will be given to those with 1:1 Federal to private funds ratio, with 
more preference given to those with greater levels of private matching 
funds.

Executive Order 12372 Review

    Applications are subject to Intergovernmental Review of Federal 
Programs as governed by Executive Order (E.O.) 12372. E.O. 12372 sets 
up a system for State and local government review of proposed Federal 
assistance applications. Applicants (other than

[[Page 28041]]

federally recognized Indian tribal governments) should contact their 
State Single Point of Contact (SPOC) as early as possible to alert them 
to the prospective applications and receive any necessary instructions 
on the State process. For proposed projects serving more than one 
State, the applicant is advised to contact the SPOC for each affected 
State. A current list of SPOCs is included in the application kit. If 
SPOCs have any State process recommendations on applications submitted 
to CDC, they should send them to Van Malone, Grants Management Officer, 
Grants Management Branch, Procurement and Grants Office, Centers for 
Disease Control and Prevention (CDC), 255 East Paces Ferry Road, NE, 
Atlanta, GA 30305, no later than 60 days after the application 
deadline. The Program Announcement Number and Program Title should be 
referenced on the document. The granting agency does not guarantee to 
``accommodate or explain'' State process recommendations it receives 
after the date.
    Indian tribes are strongly encourage to request tribal government 
review of the proposed application. If tribal governments have any 
tribal process recommendations on applications submitted to CDC, they 
should send them to Van Malone, Grants Management Officer, Grants 
Management Branch, Procurement and Grants Office, Centers for Disease 
Control and Prevention (CDC), 255 East Paces Ferry Road, NE, Atlanta, 
GA 30305, no later than 60 days after the application deadline. The 
Program Announcement Number and Program Title should be referenced on 
the document. The granting agency does not guarantee to ``accommodate 
or explain'' State process recommendations it receives after that date.

Public Health System Reporting Requirements

    This program is not subject to the Public Health System Reporting 
Requirements.

Catalog of Federal Domestic Assistance

    The Catalog of Federal Domestic Assistance number is 93.978.

Other Requirements

Paperwork Reduction Act

    Projects that involve the collection of information from 10 or more 
individuals and funded by the cooperative agreement will be subject to 
review by the Office of Management and Budget (OMB) under the Paperwork 
Reduction Act.

Human Subjects

    If the proposed project involves research on human subjects, the 
applicant must comply with the Department of Health and Human Services 
Regulations, 45 CFR Part 46, regarding the protection of human 
subjects. Assurance must be provided to demonstrate that the project 
will be subject to initial and continuing review by an appropriate 
institutional review committee. In addition to other applicable 
committees, Indian Health Service (IHS) institutional review committees 
also must review the project if any component of IHS will be involved 
or will support the research. If any American Indian community is 
involved, its tribal government must also approve that portion of the 
project applicable to it. The applicant will be responsible for 
providing assurance in accordance with the appropriate guidelines and 
form provided in the application kit.

Confidentiality

    Any personally identifying information obtained in connection with 
the delivery of services provided to any individual under any program 
that is being carried out with a cooperative agreement made under this 
announcement shall not be disclosed unless required by a law of a State 
or political subdivision or unless such an individual provides written, 
voluntary informed consent.

Women, Racial and Ethnic Minorities

    It is the policy of the Centers for Disease Control and Prevention 
(CDC) and the Agency for Toxic Substances and Disease Registry (ATSDR) 
to ensure that individuals of both sexes and the various racial and 
ethnic groups will be included in CDC/ATSDR-supported research projects 
involving human subjects, whenever feasible and appropriate. Racial and 
ethnic groups are those defined in OMB Directive No. 15 and include 
American Indian, Alaska Native, Asian, Pacific Islander, Black and 
Hispanic. Applicants shall ensure that women, racial and ethnic 
minority populations are appropriately represented in applications for 
research involving human subjects. Where clear and compelling rationale 
exist that inclusion is inappropriate or not feasible, this situation 
must be explained as part of the application. This policy does not 
apply to research studies when the investigator cannot control the 
race, ethnicity and/or sex of subjects. Further guidance to this policy 
is contained in the Federal Register Vol. 60, No. 179, pages 47947-
47951, dated Friday, September 15, 1995.

Application Submission and Deadlines

1. Preapplication Letter of Intent (LOI)

    A non-binding letter of intent-to-apply is requested from potential 
applicants. An original and two copies of a two-page, typewritten LOI 
should be submitted to the Grants Management Branch, CDC (see 
``Applications'' for address). It should be postmarked no later than 
June 13 1997. The letter should identify the announcement number, title 
of the specific research activity for which application is being 
submitted, the name and institutional affiliation of the principal 
investigator, and the identity of other key participants and 
participating institutions. No attachments, booklets, or other 
documents accompanying the LOI will be considered. The letter should 
also include the estimated total cost of the research activity and the 
percentage of the total cost being requested from CDC. The LOI does not 
influence review of funding decisions, but it will enable CDC to plan 
more efficiently, and will ensure that each applicant receives timely 
and relevant information prior to application submission.

2. Applications

    An original and two copies of the application Form PHS-5161-1 (OMB 
Number 0937-0189) must be submitted on or before July 25, 1997 to Van 
Malone, Grants Management Officer, Attention: Kathy Raible, Grants 
Management Specialist, Grants Management Branch, Procurement and Grants 
Office, Centers for Disease Control and Prevention (CDC), 255 East 
Paces Ferry Road, NE., Room 300, Mailstop E-15, Atlanta, GA 30305.

3. Deadlines

    A. Applications will meet the deadline if they are either:
    1. Received on or before the deadline date; or
    2. Sent on or before the deadline date and received in time for 
submission to the objective review committee. (Applicants must request 
a legibly dated U.S. Postal Service postmark or obtain a legibly dated 
receipt from a commercial carrier or U.S. Postal Service. Private 
metered postmarks shall not be acceptable as proof of timely mailing.)
    B. Applications that do not meet the criteria in 3.A.1 or 3.A.2. 
above are considered late applications. Late applications will not be 
considered in current competition and will be returned to the 
applicant.

[[Page 28042]]

Where To Obtain Additional Information

    A complete application package which will include program 
description, information on application procedures, etc. and business 
management technical assistance may be obtained from Kathy Raible, 
Grant Management Specialist, Grants Management Branch, Procurement and 
Grants Office, Centers for Disease Control and Prevention (CDC), 255 
East Paces Ferry Road, NE., Room 300, Mailstop E-15, Atlanta, GA 0305, 
telephone 404) 842-6592, email or via email at: <[email protected]>.
    Programmatic technical assistance may be obtained from William J. 
Kassler, M.D., M.P.H., Chief Health Services Research and Evaluation 
Branch Division of STD, National Center for HIV/STD/TB
    Prevention (NCHSTP), Centers for Disease Control and Prevention 
(CDC), 1600 Clifton Road; Mailstop E-44, Atlanta, GA 30333, telephone 
(404) 639-8276, or facsimile (404) 639-8607, INTERNET address: 
<[email protected]>.

Internet Home Page

    The announcement will be available on one of two Internet sites on 
the publication date: CDC's home page at <http://www.cdc.gov>, or at 
the Government Printing Office home page (including free access to the 
Federal Register) at <http://www.access.gpo.gov>.
    Potential applicants may obtain a copy of ``Healthy People 200'' 
(Full Report, Stock No. 017-001-00474-0), or ``Healthy People 2000'' 
(Summary Report, Stock No. 017-001-00473-1) referenced in the 
``INTRODUCTION'' through the Superintendent of Documents, Government 
Printing Office, Washington, DC 20402-9325, telephone (202) 512-1800.

    Dated: May 16, 1997.
Joseph R. Carter,
Acting Associate Director for Management and Operations, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 97-13425 Filed 5-21-97; 8:45 am]
BILLING CODE 4163-18-M